Business Context and Reporting Period
This Form 8-K was filed by Keros Therapeutics, Inc. on August 4, 2021. The report details a material definitive agreement regarding the company's headquarters lease in Lexington, Massachusetts, and references financial results for the quarter ended June 30, 2021, which were announced via a press release on August 5, 2021.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being contained in a press release (Exhibit 99.1) but are not detailed within the body of this 8-K document.
Lease Financial Terms
- Expansion Premises Rent: $34,700 per month (commencing on the Expansion Commencement Date).
- Initial Premises Rent (5,420 sq. ft.): Approximately $20,400 per month during the Extended Term.
- Initial Premises Rent (4,997 sq. ft.): Approximately $22,700 per month during the Extended Term.
- Additional Rent: The company's share of operating expenses, utilities, insurance, and taxes will increase to account for the expanded space.
Material Changes
The primary material change is the execution of the Third Amendment to the Company's lease agreement with 99 Hayden LLC. Key changes include:
- Space Expansion: Addition of 5,205 square feet of office and laboratory space to the existing 10,400 square feet.
- Term Extension: Extension of the lease term for an additional period from January 1, 2023, to March 31, 2023.
- Commencement: The expansion lease commences on the later of October 1, 2021, or the date the current tenant vacates the space.
Guidance, Outlook, and Risks
The filing does not contain specific forward-looking guidance, management commentary on future performance, or a detailed risk factor analysis beyond the standard incorporation of the press release. The document notes that the press release information is furnished and not deemed "filed" for purposes of Section 18 of the Exchange Act.
Investor Verification Checklist
- Verify the specific financial results for the quarter ended June 30, 2021, by reviewing the press release dated August 5, 2021 (Exhibit 99.1), as this 8-K does not contain the data.
- Confirm the exact "Expansion Commencement Date" once the current tenant vacates the 5,205 square feet of expansion space.
- Review the full text of the Third Amendment to Lease (to be filed as an exhibit to the Form 10-Q for the period ending June 30, 2021) for complete terms and conditions.
- Assess the impact of the increased monthly rent and operating expense obligations on the company's cash burn rate.